L. Glode
University of Colorado Denver School of Medicine
Last Updated On 2/14/2022 10:26:23 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
Company: ProTechSure Scientific |
Recipient: You |
Company: Gonex |
Recipient: You |
Company: Aurora Oncology |
Recipient: You |
|
Stock and Other Ownership Interests |
Company: ProTechSure Scientific |
Recipient: You |
Company: Gonex |
Recipient: You |
Company: Aurora Oncology |
Recipient: You |
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Janssen |
Recipient: You |
Company: Seattle Genetics |
Recipient: You |
Company: Bayer |
Recipient: You |
Company: Exelixis |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Aurora Oncology |
Recipient: You |
|
Patents, Royalties, Other Intellectual Property |
Please describe: Patents held by the University of Colorado in my name relating to GnRH and EGF toxin conjugates, Silibinin |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
Company: Janssen |
Recipient: You |
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|